(Q46990369)
Statements
1 reference
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. (English)
1 reference
William J Sandborn
1 reference
Jean-Frederic Colombel
1 reference
Walter Reinisch
1 reference
Geert D'Haens
1 reference
Douglas C Wolf
1 reference
Martina Kron
1 reference
Roopal B Thakkar
1 reference
Mary Beth Tighe
1 reference
Gert van Assche
1 reference
Andreas Lazar
1 reference
4 November 2011
1 reference
1 reference
142
1 reference
2
1 reference
257-65.e1-3
1 reference